期刊文献+

Feasibility and clinical outcomes in nonagenarians undergoing transcatheter aortic valve replacement with the LOTUSTM valve

Feasibility and clinical outcomes in nonagenarians undergoing transcatheter aortic valve replacement with the LOTUSTM valve
暂未订购
导出
摘要 Surgical aortic valve replacement (AVR) is associated with very high peri-operative risk in the nonagenarian populationflI Patients with severe aortic stenosis treated conservatively have high rates of mortality with poor quality of life and loss of independence. Transcatheter aortic valve replacement (TAVR) has been validated in the high risk elderly population as a viable alternative to surgery with comparable outcomes.
出处 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2016年第7期636-638,共3页 老年心脏病学杂志(英文版)
  • 相关文献

参考文献10

  • 1Mack MC, Szerlip M, Herbert MA, et al. Outcomes of treat- ment of nonagenarians with severe aortic stenosis. Ann Tho- rac Surg 2015; 100: 74-80.
  • 2Adams DH, Popma J J, Reardon M J, et al. Transcatheter aor- tic-valve replacement with a self-expanding prosthesis. N Engl JMed 2014; 370: 1790-1798.
  • 3Thourani VH, Jensen HA, Babaliaros V, et al. Outcomes in nonagenarians undergoing transcatheter aortic valve replace- ment in the PARTNER-I Trial. Ann Thorac Surg 100; 785-793.
  • 4Verouhis D, Yamasaki K, lvert T, et al. Transcatheter aortic valve implantation is feasible and safe in nonagenarians. JAm GeriatrSoc 2014; 62:189- 190.
  • 5Yamamoto M, Meguro K, Mouillet G, et al. Comparison of effectiveness and safety of transcatheter aortic valve implanta- tion in patients aged _> 90 years versus & < 90 years. Am J Cardiol 2012; 11O: 1156-1163.
  • 6Havakuk O, Finkelstein A1, Steinvil A, et al. Comparison of outcomes in patients < 85 versus > 85 years of age undergoing transcatheter aortic-valve implantation. Am J Cardiol 2014; 113:138- 141.
  • 7Rod6s-Cabau J, Mok M. Working toward a frailty index in transcatheter aortic valve replacement: a major move away from the "Eyeball Test". JACC Cardiovaxc lnterv 2012; 5: 982 -983.
  • 8Meredith Am IT, Walters DL, Dumonteil N, et al. Tran- scatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. J Am Coll Cardio12014; 64: 1339-1348.
  • 9Bates ER. Treatment options in severe aortic stenosis. Circu- lation 2011; 124:355 -359.
  • 10Siontis GC, Jiini P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol 2014; 64: 129-140.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部